AVIR — Atea Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Atea Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21.7	850	764	647	578
Net Total Accounts Receivable
Net Total Receivables	—	5.82	0	—	—
Prepaid Expenses
Total Current Assets	21.9	863	772	661	590
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.041	0.048	0.184	4.09	3.12
Other Long Term Assets
Total Assets	22.1	864	773	667	595
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.44	316	56.9	18.5	32.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.53	316	62.8	26.1	39.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	19.5	548	710	641	555
Total Liabilities & Shareholders' Equity	22.1	864	773	667	595
Total Common Shares Outstanding